People on the move – April/May 2021

Welcome to People on the move, a new concept we’re trialling for Insight’s e-newsletter and website to keep the ophthalmic industry updated on new appointments and personnel changes. Read more

Novartis secures PBS recommendation for Beovu

An independent expert panel has recommended Novartis’ treatment Beovu be subsidised through the Pharmaceutical Benefits Scheme (PBS) for neovascular age-related macular degeneration (nAMD) patients as a second-line anti-VEGF treatment. Read more